Radiotherapy

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

Provided to more than a quarter of cancer patients, targeted radiotherapy is cutting edge, can be curative, and has come a long way from its origins.

A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials – we tell the story from discovery to translation.

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.

We’re investing £56 million into radiotherapy research that will be carried out by a network of specialist institutes across the UK.

Cancer Research UK has today announced a new radiotherapy research network, RadNet, to accelerate the development of advanced radiotherapy techniques.

Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?

Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.